The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial

May 2011
Diabetes Care;May2011 Supplement 2, Vol. 34, pS107
Academic Journal
The article discusses findings of a trial aimed at determining the effects of Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid on atherosclerotic cardiovascular disease outcomes in patients with type 2 diabetes who are at high risk. Some factors that increase the risk of atherosclerotic cardiovascular disease include hypertension, obesity and dyslipidemia. Fenofibrate was used in the trial. In this trial, men and women with type 2 diabetes have been enrolled, in which the primary outcome include occurrence of myocardial infarction.


Related Articles

  • Nutrapharmacology of Tocotrienols for Metabolic Syndrome. Weng-Yew, Wong; Brown, Lindsay // Current Pharmaceutical Design;7/11/2011, Vol. 17 Issue 21, p2206 

    Metabolic syndrome is defined as a set of health risk factors that are associated with an increased chance of cardiovascular diseases and type 2 diabetes. These include abdominal obesity, hyperglycemia, impaired glucose tolerance, dyslipidemia, and hypertension. Interventions in metabolic...

  • Obesity and alcohol misuse. Noone, Peter // Occupational Medicine;Feb2012, Vol. 62 Issue 2, p159 

    No abstract available.

  • Contributors to Mortality in High-Risk Diabetic Patients in the Diabetes Heart Study. Cox, Amanda J.; Fang-Chi Hsu; Freedman, Barry I.; Herrington, David M.; Criqui, Michael H.; Carr, J. Jeffrey; Bowden, Donald W. // Diabetes Care;Oct2014, Vol. 37 Issue 10, p2798 

    OBJECTIVE Not all individuals with type 2 diabetes and high coronary artery calcified plaque (CAC) experience the same risk for adverse outcomes. This study examined a subset of high-risk individuals based on CAC >1,000 mg (using a total mass score) and evaluated whether differences in a range...

  • Metabolic Syndrome: Does it Differ Between Women and Men? Rochlani, Yogita; Pothineni, Naga; Mehta, Jawahar // Cardiovascular Drugs & Therapy;Aug2015, Vol. 29 Issue 4, p329 

    Cardiovascular disease represents a massive healthcare burden worldwide. Gender differences in the pathophysiology, presentation and prognosis of cardiovascular disease have been described in the literature. Metabolic syndrome, characterized by a cluster of metabolic abnormalities is associated...

  • Mushrooms and health. Dragsted, Lars Ove // American Journal of Clinical Nutrition;Sep2019, Vol. 110 Issue 3, p546 

    The author comments on a study by D. H. Lee and colleagues on the link between mushroom intake and risk of cardiovascular disease and type 2 diabetes. He discusses the failure of the study to elaborate on any associations of mushrooms with other food, factors that might help reduce or control...

  • Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum. Cefalu, William T.; Bray, George A.; Home, Philip D.; Garvey, W. Timothy; Klein, Samuel; Pi-Sunyer, F. Xavier; Hu, Frank B.; Raz, Itamar; Van Gaal, Luc; Wolfe, Bruce M.; Ryan, Donna H. // Diabetes Care;Aug2015, Vol. 38 Issue 8, p1567 

    As obesity rates increase, so too do the risks of type 2 diabetes, cardiovascular disease, and numerous other detrimental conditions. The prevalence of obesity in U.S. adults more than doubled between 1980 and 2010, from 15.0 to 36.1%. Although this trend may be leveling off, obesity and its...

  • Role of dietary factors in ethnic differences in early risk of cardiovascular disease and type 2... Lindquist, Christine H.; Gower, Barbara A. // American Journal of Clinical Nutrition;Mar2000, Vol. 71 Issue 3, p725 

    Explores whether dietary factors explain ethnic differences in early risk of cardiovascular disease and type 2 diabetes mellitus. Ethnic differences in blood lipids and insulin sensitivity measures; Lower traiacylglycerol concentrations among Afro-American children as compared to their white...

  • The CR Wayâ„¢ to Great Glucose Control. McGlothin, Paul; Averill, Meredith // Life Extension;Apr2012, Vol. 18 Issue 4, p1 

    No abstract available.

  • Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy. Chen, J.W.; Gall, M.A. // BMJ: British Medical Journal (International Edition);11/25/95, Vol. 311 Issue 7017, p1405 

    Verifies the significance of serum von Willebrand factor concentration in cardiovascular morbidity and mortality in non-insulin diabetic patients. Rise in serum von Willebrand concentration with increasing urinary albumin excretion; Association between cardiovascular disease and higher...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics